drugset / Trial / NCT03372161
Corticosteroid Lumbar Epidural Analgesia for Radiculopathy
Phase 3
Completed
401 enrolled
Scilex Pharmaceuticals, Inc.
Semnur Pharmaceuticals, Inc. · collabWorldwide Clinical Trials · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
This is a research study of SP-102, an experimental medication designed to relieve pain in patients with a specific type of leg pain. The medication is given once by your healthcare professional, with a possibility of a second injection as early as about 1 month after the first treatment. The purpose of the study is to measure how well a single injection of the experimental medication, SP-102, relieves pain. The study will also investigate the side effects of SP-102.
Timeline
- Start
- 2017-12-08
- Primary completion
- 2021-08-20
- Completion
- 2022-01-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SP-102 | Unknown | — | Other |